Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Share Issue/Capital Change 2024

Feb 15, 2024

62142_rns_2024-02-15_64f8adb3-81f1-4041-8d9b-923f859adf94.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [199 x 68] intentionally omitted <==

Date : February 15, 2024

BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department PhirozeJeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS

Sub: Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 towards issue of Duplicate Share Certificate

Dear Sir/Madam,

We have received intimation from our Registrar and Transfer Agent, M/s Bigshare Services Private Limited today i.e. on February 15, 2024 regarding the duplicate share certificates of the Company that have been issued, the details of which are as follows:

Name ofShareholder FolioNumber(s) OldCertificateNumber NewCertificateNumber DistinctiveNumber(s) No. ofShares
Antony J Vypana A001340 729 1119 2275521- 1000
2276520

Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, a letter of confirmation will be issued to the securities holder / claimant upon completion of necessary procedures regarding duplicate share certificates.

We request you to take the aforesaid on record.

Thanking You.

Yours faithfully,

For Marksans Pharma Limited

Digitally signed by HARSHAVARDH HARSHAVARDHAN PANIGRAHI AN PANIGRAHI Date: 2024.02.15 15:37:54 +05'30'

Harshavardhan Panigrahi Company Secretary

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: [email protected] www.marksanspharma.com

CIN: L24110MH1992PLC066364